Literature DB >> 12053962

Efficacy of beta-cyclodextrin against experimental cryptosporidiosis in neonatal lambs.

J A Castro-Hermida1, Y González-Losada, F Freire-Santos, M González-Warleta, M Mezo-Menéndez, E Ares-Mazás.   

Abstract

The efficacy of beta-cyclodextrin against experimental Cryptosporidium parvum infection was evaluated in neonatal lambs. The animals were treated by oral administration of the drug at 1 g/kg of body weight during 3 consecutive days. Preventive treatment was started within 1 day of birth, and therapeutic treatment was initiated at the onset of diarrhea following confirmation of infection. Disease development and drug efficacy were evaluated by monitoring the presence or absence of diarrhea and oocyst shedding from birth until 30 days of age. Weight gains at 15 and 30 days of age were also recorded. Beta-cyclodextrin was highly effective as a prophylactic treatment; 1 animal did not acquire the infection, diarrhea was prevented in infected animals, and there was a considerable decrease in oocyst shedding. The therapeutic treatment was effective in decreasing the severity of diarrhea and the duration of oocyst shedding. The animals tolerated the drug well, and there was a significant increase in their body weights.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12053962     DOI: 10.1645/0022-3395(2002)088[0185:EOCAEC]2.0.CO;2

Source DB:  PubMed          Journal:  J Parasitol        ISSN: 0022-3395            Impact factor:   1.276


  2 in total

1.  An Irish perspective on Cryptosporidium. Part 2.

Authors:  Annetta Zintl; Grace Mulcahy; Theo de Waal; Valerie de Waele; Catherine Byrne; Marguerite Clyne; Nicholas Holden; Seamus Fanning
Journal:  Ir Vet J       Date:  2006-09-01       Impact factor: 2.146

2.  Activity of an anti-inflammatory drug against cryptosporidiosis in neonatal lambs.

Authors:  José Antonio Castro-Hermida; Ignacio García-Presedo; Marta González-Warleta; Mercedes Mezo; Soledad Fenoy; Cristina Rueda; Carmen del Aguila
Journal:  Vet Parasitol       Date:  2008-05-22       Impact factor: 2.738

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.